
Description:
1.IntendedUse
TheGenWayCytomegalyIgMAntibodyELISATestKithasbeendesignedforthedetectionand thequantitativedeterminationofspecificIgMantibodiesagainstCytomegalovirusinserumand plasma.FurtherapplicationsinotherbodyfluidsarepossIBLeandcanberequestedfromthe TechnicalServiceofGenWay. Thisassayisintendedforresearchuseonly.
2.GeneralInformation
Cytomegalyiscausedbyaviralinfection,whichshowsaninapparentprogression,howeverleads toserioussymptomswithimmune-compromisedadultsandnewborns. Thecytomegalyvirus(CMV)withaparticlediameterof100nm(inclusiveenvelopethevirion measures200nm)belongstothefamilyofherpesviridaelikeHerpes1andHerpes2.The transmissioniseffectedviasalivaandbylong-termintimatecontacts.Theincubationtimeis2-10 daysforprimaryinfections. CytomegalyappearsoftenduringthegrAvidity,andperyearupto5%ofthepregnantwomenshow clinicalsignsofthedisease.Intheearlyphasetheillnessfrequentlyremainsundetected,andthe affectedwomenthemselvesshownosymptoms.Whenhowevernewbornsareinfected(1%ofthe births),theseshowin10%ofthecasesdiseasesymptomswithlatedamageslikeretinitis,ulceraof themucousmembrane,viralpneumonia,meningitis,microencephaly,hydrocephalusandskin ulcerations.Theincidenceofwomencapableofchildbearingisestimatedtobe65%,sothatan assessmentoftheimmunestatusbeforepregnancyismandatory.Afteranegativeresult,acontrol checkisrecommendedinthe20th weekofgestation. Besidesthesymptomatictreatmentaspecifictherapywithphosphonoformateandgancicloviris possible.Avaccinationdoesnotexist,sothatinthecaseofaninfectiononlypassiveCMV immunoglobulinsareadmiNISTered. Togetherwiththedifferentialassessmentoftheabovementionedsymptoms,thediagnosisis performedclinicallyintissuesamplesviatheso-called“owleyes”.Thefollowinglaboratory methodsareavailable:CFandELISA,determinationofvirusnucleicacid(PCR)aswellasvirus isolation(cellculture).SEROlogically,IgGandIgMantibodiescanbedetectedandquantitatedby theELISAtechnique.AlsothemeasurementoftheavidityoftheIgGmoleculesisappropriate.
3.PrincipleoftheTest
TheGenWayCytomegalyIgMantibodytestkitisbasedontheprincipleoftheenzyme immunoassay(EIA).Cytomegalovirusantigenisboundonthesurfaceofthemicrotiterstrips. Dilutedsampleserumorready-to-usecalibratorsarePipettedintothewellsofthemicrotiterplate. AbindingbetweentheIgMantibodiesoftheserumandtheimmobilizedCytomegalovirusantigen takesplace.Afteraonehourincubationatroomtemperature,theplateisrinsedwithdilutedwash solution,inordertoremoveunboundmaterial.Thenready-to-useanti-human-IgMperoxidase conjugateisaddedandincubatedfor30minutes.Afterafurtherwashingstep,thesubstrate(TMB) solutionispipettedandincubatedfor20minutes,inducingthedevelopmentofabluedyeinthe wells.Thecolordevelopmentisterminatedbytheadditionofastopsolution,whichchangesthe colorfrombluetoyellow.Theresultingdyeismeasuredspectrophotometricallyatthewavelength of450nm.TheconcentrationoftheIgMantibodiesisdirectlyproportionaltotheintensityofthe color.
AdditionalInformation:
Name | CytomegalyIgMELISA |
---|---|
RelatedProductNames | CytomegalyIgMELISA |
Applications | EnzymeimmunoassaybasedonmicrotiterplateforthedetectionandquantitativedeterminationofhumanIgMantibodiesagainstCytomegalovirusinserumandplasma |
IntendedUse | ResearchUseOnly |